• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
+49 (0) 69 / 606 278 – 0
[email protected]
Contact form
Patentanwaltskanzlei

Patentanwaltskanzlei

  • Deutsch

+49 (0) 69 / 606 278 – 0

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • xing
  • Email
MENUMENU
  • Services
    • Advice On Protective IP Rights
    • Patent Application /TM Registration
    • Enforcement Of IP Rights
    • Defence Against IP Rights Enforcement
    • Costs
  • Company
    • Fields of Law
      • Patent Law
      • Utility Model Law
      • Employees‘ Inventions
      • Trademark Law
      • Design Law
      • Trademark and Product Piracy
      • Expert Opinions
    • Our Law Firm
      • Dr. Tim Meyer-Dulheuer
      • Dr. Klaus Zimmermann
      • Zhichao Ying
      • Walter Benjamin Feldheim
    • Commitment
  • Contact
    • Where To Find Us
    • Write us!
    • Request call back
  • Blog

Warm socks on top? ECJ, OVG Münster and fixed prices for medicines

30. November 2017

No warm socks on top when buying medicines in the pharmacy! This is because German pharmacists are not allowed to grant any monetary benefits when purchasing price-linked medicines, such as vouchers, discounts or advertising gifts. This is true, although the ECJ ruled differently on price fixing, the OVG Münster recently ruled and the OLG Frankfurt also ruled, published yesterday.

Price fixing prevents the addition of cuddly socks

KuschelsockenIt is forbidden for German pharmacists to deviate from the uniform price resulting from the drug price regulation. The addition of cuddly socks when buying medicines would be a violation of the price maintenance (medication products law § 78. 1. + 78.2.) This also applies to the granting of discounts or other price reductions as well as to benefits and advertising supplements (medical products advertising law § 7.1 Nr. 2). Advertising is also prohibited. Monetary benefits may not be granted on any price-based medicinal products at all, this applies to both prescription and other price-based medicines.

Nor can there be rolls from the pharmacy. In this case that was publised by the Higher Regional Court in Frankfurt yesterday, a pharmacist from Darmstadt had issued vouchers for bread rolls when buying medicines. The Higher Regional Court in Frankfurt also ruled in this case (Case No. 6 U 164/16) that this was a violation of the price fixing for pharmaceuticals. However, the Higher Regional Court of Frankfurt allows the revision with reference to national discrimination.

The background

The plaintiffs in this case are two pharmacists from North Rhine-Westphalia. In 2013 and 2014, the two plaintiffs issued vouchers that could be redeemed when the prescription was handed in. For example, pharmacy customers received a roll of gift wrapping paper and a pair of cuddly socks for the vouchers. The Apothekerkammer Westfalen-Lippe judged this to be a violation of the price fixing for prescription drugs and therefore demanded to refrain from issuing such vouchers. The plaintiffs turned against this. They argue that the judgment of the Court of Justice of the European Union of 19 October 2016-Rs C-148/15 calls into question the validity of the price fixing of medicines for German pharmacies as well.

The Minden Administrative Court dismissed the actions.

The OVG Münster confirms the dismissal of the complaint

The OVG Münster confirmed the decision of the Administrative Court and did not allow any appeal to the BVerwG (13 A 2979/15;13 A 3027/15). The court argued:

  • PharmacieThe price fixing rules are constitutional. They serve to ensure an even supply of medicines throughout Germany and do not violate either the fundamental right of freedom to practise one’s profession or the principle of equality.
  • The two plaintiffs have infringed the price maintenance agreement because the payment in kind promised in the voucher makes the purchase of the price-linked drug appear cheaper for the customer.
  • The customer saves his or her own efforts by receiving a product of daily use when he or she submits the voucher. The small value (less than 0.50 €) is insignificant in the context of price fixing, because there is no minimum limit for (permissible) deviations.

Union law allows for national law

At the same time, the court also confirmed that it is forbidden for German pharmacists to depart from the uniform price resulting from the drug price regulation. In particular, the granting of discounts or other price reductions as well as for donations and advertising gifts and for advertising are mentioned. This applies despite the judgment of the ECJ last year. In this ruling (C-148/15), the European Court of Justice stated that the German price fixing for pharmaceuticals does not apply to foreign pharmacies when dispatching medicines to German customers.

Judgment C-148/15 of the ECJIn the judgment of the European Court of Justice, the German Parkinson Association (DPV) brought an action against the Central Office for Combating Unfair Competition (“Zentrale zur Bekämpfung unlauteren Wettbewerbs e. V.”) concerning the fixing of uniform pharmacy sales prices for prescription-only human medicines in German law. The reason for the dispute was the different treatment of Union and national law in relation to fixed prices. The DPV is a self-help organisation for Parkinson’s patients. In July 2009, the DPV promoted a cooperation between the DPV and the Dutch mail-order pharmacy DocMorris, and presented its members with a bonus system that provided for various bonuses for prescription Parkinson’s medications available only from pharmacies when they were purchased by members of the DPV of DocMorris.

The European Court of Justice ruled on the free movement of goods via fixed prices for prescription drugs in Germany. The DPV won the lawsuit and the European court allows the members to benefit from discounts. The court argued that traditional pharmacies are generally better placed than mail-order pharmacies to provide patients with individual on-site advice and emergency medical care. Since mail-order pharmacies cannot adequately replace such a supply with their limited range of services, it can be assumed that price competition is a more important competitive factor for them than for traditional pharmacies, because it depends on them whether they can gain direct access to the German market and remain competitive on it.

The Court also pointed out that this did not affect its assessment of the price maintenance rules. As regards national measures in the field of public health, the Court of Justice has ruled on several occasions that, among the goods and interests protected by the Treaty, human health and life are of the highest priority and that it is for the Member States to determine at what level they wish to guarantee the protection of public health.

OLG Frankfurt thematizes discrimination of German pharmacists

The OVG Münster and the OLG Frankfurt therefore followed the ruling of the European Court of Justice, as it allows national regulations on price fixing and its enforcement for medicines. It is often criticised that this ruling for domestic pharmacists is also a form of discrimination of German pharmacists. In the case of the bread roll vouchers from the pharmacy in Darmstadt, the OLG Frankfurt clearly named the discrimination against German nationals. In view of the fundamental importance of the question of discrimination against nationals, the Senate has allowed the revision “, the OLG’s press release states in a concise and clear manner. And it will be interesting to see if and when the national legislator will adapt the German regulations to European reality.

 

Do you need an attorney for in national or European competetion rules?

Please take your chance and contact us. Our lawyers are experienced in trademark and patent law, national and international law.

CAT-call_en

 

Sources:

text:

press release of OLG Frankfurt (29 Nov 2017)

press release of OVG Münster (Sept 2017)

Curia Judgement C-148/15 of the ECJ (Oct 2016)

pictures:

Kruscha /pixabay.com / CCO License  || FotoArt-Treu / pixabay.com / CCO License

  • share  
  • share 
  • share 
  • share 
  • share 

Category iconHealthcare & Lifesciences Tag iconDocMorris,  EU,  EuGH

Primary Sidebar

More articles about: Healthcare & Lifesciences

All articles

Blog Menu

  • Design Law
  • Healthcare & Lifesciences
  • International Intellectual Property
  • Licenses
  • News from our law firm
  • Overall
  • Patent Law
  • Product- and Trademark piracy
  • Trademark Law

Recent Posts

  • What is the public allowed to know? 3. June 2024
  • BPatG: Patent claim of cancer drug on active substance as salt 7. March 2022
  • Grant for European IP Protection: SME Fund 2022 4. March 2022
  • CODE-X vs. Cody’s: Likelihood of confusion in drinks? 25. February 2022

Fields of Law

  • Patent Law
  • Utility Model Law
  • Employees’ Inventions
  • Trademark Law
  • Design Law
  • Trademark and Product Piracy
  • Expert Opinions
  • Costs

Das könnte Sie auch interessieren:

7. March 2022
BPatG: Patent claim of cancer drug on active substance as salt

BPatG: Patent claim of cancer drug on active substance as salt

6. December 2021
Bioabsorbable medical devices: Advertising permitted

Bioabsorbable medical devices: Advertising permitted

26. November 2021
ECJ: Marketing authorisation of medicinal products according to national rules

ECJ: Marketing authorisation of medicinal products according to national rules

15. October 2021
Amendments in patent act China relating Pharmacy

Amendments in patent act China relating Pharmacy

5. October 2021
Merck and Merck & Co: dispute over digital global perception

Merck and Merck & Co: dispute over digital global perception

6. July 2021
Digitalisation in medical technology: medical purpose?

Digitalisation in medical technology: medical purpose?

Contact us or request a call back

+49 (0) 69 / 606 278 – 0
[email protected]
Request a call back

Footer

Contact

Hanauer Landstrasse 287
D – 60314 Frankfurt am Main
Deutschland
+49 (0) 69 / 606 278 – 0
+49 (0) 69 / 606 278 – 199
[email protected]

Office Hours
Moday – Friday:   08:00-18:00

Fields of Law

  • Patent Law
  • Utility Model Law
  • Employees’ Inventions
  • Trademark Law
  • Design Law
  • Trademark and Product Piracy
  • Expert Opinions
  • Costs

Law Firm

  • Request non-binding call back
  • Company
  • Our Law Firm
  • ISO Certificate
  • Privacy Policy
  • Data handling for clients
  • Imprint

Follow Us

  • Facebook
  • Twitter
  • LinkedIn
  • xing
  • Email

Newsletter Signup

Newsletter INT

© Meyer-Dulheuer MD Legal Patentanwälte PartG

Contact Form

 

Give us a call, send us an email or fill out the contact form.

+49 (0) 69 / 606 278 – 0
[email protected]

Rückruf INT

Please note: If we deal specifically with your individual case, this is what is known as an initial consultation. In accordance with Section 34 of the Rechtsanwaltsvergütungsgesetz, this incurs one-off costs of 190 euros plus MwSt. We will be happy to assist you in a personal consultation after our telephone call.

Kontaktformular

 

Rufen Sie uns an, schicken Sie uns eine Mail oder füllen Sie das Kontaktformular aus.

+49 (0) 69 / 606 278 – 0
[email protected]

Rückruf

Um dieses Angebot nutzen zu können, müssen Sie der Speicherung Ihrer personenbezogenen Daten zustimmen. Wir behandeln diese streng vertraulich und verwenden sie nur zur Kontaktaufnahme mit Ihnen. Mehr dazu lesen Sie in unserer Datenschutzerklärung.

Bitte beachten Sie: Wenn wir uns konkret mit Ihrem Einzelfall befassen, ist dies eine sogenannte Erstberatung. Für eine solche entstehen gemäß § 34 Rechtsanwaltsvergütungsgesetz einmalige Kosten in Höhe von 190 Euro plus MwSt. Gerne helfen wir Ihnen im Anschluss an unser Telefonat in einem persönlichen Beratungsgespräch weiter.